logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
P

Pavel Klener

Charles University
H指数:31
被引数:2,867

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Baseline Molecular Profile of Late Relapse: Identifying Drivers of Delayed Recurrence in DLBCL

晚期复发的基准分子特征：识别弥漫性大B细胞淋巴瘤延迟复发的驱动因素

Hematological Oncology
IF3.9
2026-10-130
OAAI
Michal Masar; Joseph P. Novak; Janek S. Walker; Prokop Vodicka; Abigail R. Dropik; Zilin Xianyu; Matthew J. Maurer; Thomas M. Habermann; Eric Mou; Rebecca L. King; Kerstin Wenzl; Thomas E. Witzig; Stephen M. Ansell; Pavel Klener; James R. Cerhan; Marek Trneny; Yucai Wang; Magdalena Klanova; Anne J. Novak
EHA–EU MCL network guidelines for diagnosis and treatment of mantle cell lymphoma

EHA–EU MCL网络关于套细胞淋巴瘤诊断与治疗指南

HemaSphere
IF14.6
2025-10-220
OAAI
Mats Jerkeman; Igor Aurer; Elias Campo; Chan Y. Cheah; Jonathan Clark; Jeanette Doorduijn; Toby A. Eyre; Martin Fehr; Eva Giné; Maria Gomes da Silva; Pavel Klener; Marco Ladetto; Vincent Ribrag; Ofer Shpilberg; Jan Walewski; Martin Dreyling; the EHA Guidelines Committee and the European MCL Network
Risk of central nervous system versus systemic relapse in patients with diffuse large B-cell lymphoma treated with R-CHOP: What should we focus on?

中枢神经系统复发与系统性复发风险在采用R-CHOP方案治疗的弥漫性大B细胞淋巴瘤患者中的比较：我们应该关注什么？

HemaSphere
IF14.6
2025-09-090
OAAI
Magdalena Klanova; Samuel Hricko; Michal Masar; Prokop Vodicka; David Salek; Natasa Kopalova; Petra Blahovcova; Daniela Kuruczova; Katerina Benesova; Jozef Michalka; Jan Koren; Pavel Klener; Andrea Janikova; Marek Trneny
Circulating tumour DNA as a predictor of survival of patients with diffuse large B-cell lymphoma in a daily practice

循环肿瘤DNA作为弥漫性大B细胞淋巴瘤患者生存的预测因子在临床实践中的应用

British Journal of Haematology
IF3.8
2025-09-070
PREAI
Prokop Vodicka; Iva Hamova; Adriana Velasova; Kristyna Kupcova; Petra Zemankova; Petr Nehasil; Anton Tkachenko; Katerina Lochovska; Sarka Muzikova; Sarka Hrabetova; Jitka Dlouha; Petra Blahovcova; Tomas Frouz; Jana Senavova; Lucie Dlouha; Kamila Polgarova; Magdalena Klanova; Jana Salkova; Katerina Benesova; Pavel Klener; Marek Trneny; Ondrej Havranek
Antibody polymer drug conjugates with increased drug to antibody ratio: CD38-targeting nanomedicines for innovative therapy of relapsed lymphomas

抗体聚合物药物偶联物，其药物与抗体比率增加：靶向CD38的纳米药物，用于复发性淋巴瘤的创新治疗

Journal of Controlled Release
IF11.5
2025-05-210
PRE
Ondřej Lidický; Nicol Renešová; Júlia Kudláčová; Marcela Filipová; Tereza Běláková; Petra Kovaříková; Dmitry Manakov; Jan Pankrác; Alexandra Dolníková; Eva Pokorná; Pavel Klener; Tomáš Etrych
Long-term adaptation of lymphoma cell lines to hypoxia is mediated by diverse molecular mechanisms that are targetable with specific inhibitors
CELL DEATH DISCOVERY
IF7
2025-02-180
OAAI
Daumova, Lenka; Manakov, Dmitry; Petrak, Jiri; Sovilj, Dana; Behounek, Matej; Andera, Ladislav; Vit, Ondrej; Souckova, Olga; Havranek, Ondrej; Dolnikova, Alex; Renesova, Nicol; Tuskova, Liliana; Winkowska, Lucie; Bettazova, Nardjas; Kupcova, Kristyna; Kalbacova, Marie Hubalek; Sikorova, Miriama; Trneny, Marek; Klener, Pavel
Exploiting TCF3-Driven Oncogenic Circuits in Burkitt Lymphoma

利用TCF3驱动的癌基因回路治疗Burkitt淋巴瘤

BLOOD
IF23.1
2024-11-050
PRE
Loeber, Jens; Serin, Nazli; Ali, Salaheddine; Vockova, Petra; Werth, Marek; Richter, Julia; Kirchner, Marieluise; Sahay, Shashwat; Bohnenberger, Hanibal; Kupcova, Kristyna; Wurm-Kuczera, Rebecca; Chapuy, Claudia; Wienand, Kirsty; Bojarczuk, Kamil; Grewe, Viviane; Guenther, Jenniffer; Ishaque, Naveed; Stroebel, Philipp; Mertins, Philipp; Havranek, Ondrej; Klapper, Wolfram; Keller, Ulrich; Etrych, Tomas; Klener, Pavel; Chapuy, Bjorn
Inhibition of FLT3-ITD Kinase in Acute Myeloid Leukemia by New Imidazo[1,2-b]pyridazine Derivatives Identified by Scaffold Hopping
JOURNAL OF MEDICINAL CHEMISTRY
IF6.8
2023-08-035
OAAI
Brehova, Petra; Reznickova, Eva; Skach, Krystof; Jorda, Radek; Dejmek, Milan; Vojackova, Veronika; Sala, Michal; Kovalova, Marketa; Dracinsky, Martin; Dolnikova, Alexandra; Strmen, Timotej; Kinnertova, Monika; Chalupsky, Karel; Dvorakova, Alexandra; Gucky, Tomas; Kaiserova, Helena Mertlikova; Klener, Pavel; Nencka, Radim; Krystoy, Vladimir
Activity of tafasitamab in combination with rituximab in subtypes of aggressive lymphoma
FRONTIERS IN IMMUNOLOGY
IF5.9
2023-07-311
OAAI
Patra-Kneuer, Maria; Chang, Gaomei; Xu, Wendan; Augsberger, Christian; Grau, Michael; Zapukhlyak, Myroslav; Ilieva, Kristina; Landgraf, Karin; Mangelberger-Eberl, Doris; Yousefi, Kasra; Berning, Philipp; Kurz, Katrin S.; Ott, German; Klener, Pavel; Khandanpour, Cyrus; Horna, Pedro; Schanzer, Jurgen; Steidl, Stefan; Endell, Jan; Heitmueller, Christina; Lenz, Georg

研究方向

暂未获取到该数据
M
Marek Trněný
H 指数:68论文数:757被引数:2.5万
M
Magdalena Klánová
H 指数:15论文数:124被引数:1,119
R
Robert Pytlík
H 指数:28论文数:184被引数:2,321
A
Andrea Janíková
H 指数:25论文数:273被引数:1,829
F
Forsterova, Kristina
H 指数:0论文数:1被引数:0
P
Petra Vočková
H 指数:13论文数:50被引数:785
H
Heidi Móciková
H 指数:17论文数:182被引数:2,089
E
Eva Pokorná
H 指数:14论文数:102被引数:1,212
R
Radek Jakša
H 指数:13论文数:65被引数:535
D
David Belada
H 指数:32论文数:346被引数:7,841